Best Weight Loss Injections - Lowest Prices in the UK
Best Weight Loss Injections - Lowest Prices in the UK
Takes less than 2 minutes to complete 100% online
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
Mounjaro Weight Loss Injections (Tirzepatide) KwikPen
Wegovy (Semaglutide) Weight Loss Injection
Wegovy® Oral Tablets (Semaglutide Pill): PRE-ORDER
Best Weight Loss Injections - Lowest Prices in the UK
Published on: June 03, 2026
When searching for the best weight loss injections lowest prices UK, transparent pricing and clinical expertise matter. At Cured Pharmacy, we offer genuine UK-licensed weight loss injections including Mounjaro, Wegovy, and Saxenda with upfront pricing, free online consultations with UK prescribers, and discreet next-day delivery across the United Kingdom.
How Weight Loss Injections Work in the UK
Weight loss injections licensed in the UK belong to a class of medications called GLP-1 receptor agonists, with newer dual-agonist treatments now available. These prescription medicines work by mimicking natural hormones that regulate appetite, blood sugar levels, and gastric emptying, helping patients achieve clinically significant weight reduction when combined with lifestyle modifications [1].
The most advanced option, Mounjaro (tirzepatide), is the first dual GIP/GLP-1 receptor agonist approved by the MHRA for weight management. Clinical trials demonstrate that tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, producing superior weight loss outcomes compared to single-pathway treatments [2]. In the SURMOUNT-1 trial, patients receiving the highest dose achieved an average body weight reduction of 22.5% over 72 weeks [2].
Wegovy (semaglutide) and Saxenda (liraglutide) are single GLP-1 receptor agonists that have been available in the UK for several years. The STEP clinical trial programme showed that semaglutide 2.4mg produced an average weight loss of 14.9% over 68 weeks, whilst liraglutide studies demonstrated average reductions of 8-9% [3][4]. All three medications require a prescription following clinical assessment by a UK-registered prescriber.
Comparing Weight Loss Injection Prices Across the UK Market
Price transparency remains a significant challenge when purchasing weight loss injections in the UK, with many pharmacies requiring full consultation completion before revealing costs. At Cured Pharmacy, we display all prices upfront, allowing you to make informed decisions before starting your clinical assessment.
Mounjaro pricing starts from £135.00 for UK patients, representing competitive value for the most clinically effective weight loss injection currently licensed. The final cost depends on your prescribed maintenance dose, which your UK prescriber determines based on your individual response and tolerability during the titration phase.
When evaluating pricing across the UK market, consider the complete service package rather than price alone. Our lowest price guarantee includes free clinical consultations with UK-registered prescribers, discreet packaging, genuine UK-licensed medications dispensed by our GPhC-registered pharmacy (9012511), and transparent pricing with no hidden consultation fees.
What's Included in Your Weight Loss Injection Service
Every weight loss injection prescription at Cured Pharmacy includes a comprehensive clinical assessment by UK prescribers, ongoing support throughout your treatment journey, and access to our superintendent pharmacist Tarun Kumar (GPhC 2233073) for medication queries. We dispense only genuine UK-licensed medicines with full patient information leaflets, injection training resources, and discreet delivery to your preferred UK address.
Mounjaro vs Wegovy vs Saxenda: Clinical Differences Explained
Whilst all three medications belong to the incretin-based therapy class, they differ significantly in mechanism, dosing frequency, and clinical outcomes. Mounjaro (tirzepatide) uniquely activates both GIP and GLP-1 receptors, producing more substantial weight loss than single-receptor medications in head-to-head trials [5].
Wegovy (semaglutide) is administered once weekly via subcutaneous injection, with a gradual dose escalation from 0.25mg to a maintenance dose of 2.4mg over 16-20 weeks. Saxenda (liraglutide) requires daily injections, starting at 0.6mg and increasing to a maximum of 3mg daily. The less frequent dosing schedule of Mounjaro and Wegovy often improves treatment adherence compared to daily injection regimens [3][4].
Your UK prescriber will recommend the most appropriate treatment based on your medical history, current medications, weight loss goals, and individual circumstances. Factors including previous treatment responses, injection frequency preference, and specific contraindications all influence this clinical decision. All three medications are prescription-only and require ongoing monitoring by healthcare professionals.
Eligibility Criteria for Weight Loss Injections in the UK
NICE guidelines recommend considering GLP-1 receptor agonists for weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities such as type 2 diabetes, hypertension, or obstructive sleep apnoea [6]. Your online consultation will assess your suitability based on current UK prescribing criteria, medical history, and contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
| Treatment | Active Ingredient | Injection Frequency | Starting Price | Average Weight Loss* |
|---|---|---|---|---|
| Mounjaro | Tirzepatide (dual GIP/GLP-1) | Once weekly | From £124.99 | Up to 22.5% (72 weeks) |
| Wegovy | Semaglutide (GLP-1) | Once weekly | From £69.00 | Up to 14.9% (68 weeks) |
| Saxenda | Liraglutide (GLP-1) | Once daily | From £68.00 | Up to 8-9% (56 weeks) |
Expected Results and Clinical Outcomes from Weight Loss Injections
Clinical trial data provides realistic expectations for weight loss outcomes, though individual results vary based on adherence, lifestyle modifications, and metabolic factors. The SURMOUNT-1 trial demonstrated that 91% of participants on the highest Mounjaro dose achieved at least 5% body weight reduction, with 57% achieving 20% or greater reduction [2].
The STEP trial programme for Wegovy showed that 86.4% of participants achieved at least 5% weight loss, with 50.5% reaching 15% or greater reduction over 68 weeks [3]. For Saxenda, clinical studies demonstrated that approximately 63% of patients achieved 5% or greater weight loss over one year when combined with reduced-calorie diet and increased physical activity [4].
Weight loss typically begins within the first month of treatment, with most substantial reductions occurring between weeks 12 and 52. Your UK prescriber will schedule regular follow-up assessments to monitor progress, adjust dosing if needed, and address any tolerability concerns. Sustainable weight management requires ongoing lifestyle modifications including dietary changes and increased physical activity alongside medication therapy.
Common Side Effects and Safety Considerations
Gastrointestinal side effects are the most frequently reported adverse events with GLP-1 receptor agonists, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. These effects typically occur during dose escalation phases and often diminish as your body adjusts to the medication [1][2][3].
More serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). All weight loss injections carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains unclear. Patients with personal or family history of medullary thyroid carcinoma should not use these medications [1].
Your UK prescriber will review your complete medical history during consultation to identify contraindications including pregnancy, breastfeeding, severe gastrointestinal disease, or history of pancreatitis. Regular monitoring and open communication with your healthcare team help manage side effects effectively and ensure safe, appropriate use throughout your treatment journey.
Managing Side Effects During Treatment
Most gastrointestinal side effects can be minimised through dietary modifications including smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated. Taking your injection on the same day each week (for weekly formulations) and following the prescribed dose escalation schedule reduces the likelihood of severe nausea or vomiting. Our clinical team at Cured Pharmacy provides ongoing support and practical guidance for managing tolerability concerns throughout your treatment.
How to Order Weight Loss Injections from Cured Pharmacy
Ordering prescription weight loss injections through Cured Pharmacy follows a straightforward, clinically governed process. Begin by completing our free online consultation, which takes under three minutes and covers your medical history, current medications, weight loss goals, and relevant health conditions. This assessment is reviewed by UK-registered prescribers who determine your suitability for treatment.
If approved, your prescription is sent electronically to our GPhC-registered pharmacy (9012511) where superintendent pharmacist Tarun Kumar (GPhC 2233073) and our dispensing team prepare your medication. We dispense only genuine UK-licensed medicines sourced through regulated supply chains, never grey-market imports or unlicensed products.
Your weight loss injection is dispatched via discreet packaging with next-day delivery options across the UK. Each package includes full patient information leaflets, injection technique guidance, and contact details for our clinical support team. We offer ongoing prescription management with automated reminders when your next supply is due, ensuring continuity of treatment without gaps in therapy.
Ongoing Clinical Support and Prescription Management
Weight loss treatment requires regular monitoring and dose adjustments based on your individual response and tolerability. Our UK prescribers conduct periodic reviews to assess progress, modify dosing schedules if needed, and address any clinical concerns. You can contact our pharmacy team on (+44) 116 4646009 during business hours for medication queries, and our online portal provides secure messaging with prescribers for non-urgent clinical questions between scheduled reviews.
Scientific References
- Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. Retrieved from https://products.mhra.gov.uk/ [accessed 13 August 2026]
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503-515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
- National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE Guidelines. Retrieved from https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Weight loss results vary between individuals and depend on adherence to treatment, lifestyle modifications, and individual metabolic factors. Always consult a qualified healthcare professional before starting any new medication. Cured Pharmacy is a GPhC-registered online pharmacy (9012511) operating under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073).
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.